Comparison between the influence of roxadustat and recombinant human erythropoietin treatment on blood pressure and cardio-cerebrovascular complications in patients undergoing peritoneal dialysis

IntroductionRoxadustat treatment in PD patients is equivalent to ESAs in increasing hemoglobin (Hb). But blood pressure, cardiovascular parameters, cardio-cerebrovascular complications and prognosis in the two groups before and after treatment has not been sufficiently discussed.MethodsSixty PD pati...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Shuiqin Cheng, Tingting Zhou, Le Yu, Zhihong Zhang, Yunmin Chen, Man Zhang, Jingjing Cui, Wenxin Yu, Jian Zhou, Yusheng Yu
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Frontiers Media S.A. 2023-06-01
Seri Bilgileri:	Frontiers in Medicine
Konular:	roxadustat recombinant human erythropoietin peritoneal dialysis blood pressure cardio-cerebrovascular complications
Online Erişim:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1166024/full
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!